Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page’s interface/version label was updated from **Revision v3.5.2** to **Revision v3.5.3**.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedReplaced Napoli, Italy, 80138 with Naples, Italy, 80138 to standardize the study site location naming.SummaryDifference0.0%

- Check43 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0; no substantive changes to study details were observed.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check79 days agoChange DetectedFooter now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.